Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial
Yung Jue Bang, Rui Hua Xu, Keisho Chin, Keun Wook Lee, Se Hoon Park, Sun Young Rha, Lin Shen, Shukui Qin, Nong Xu, Seock Ah Im, Gershon Locker, Phil Rowe, Xiaojin Shi, Darren Hodgson, Yu Zhen Liu, Narikazu Boku
Dive into the research topics of 'Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial'. Together they form a unique fingerprint.